Drug Interactions between adalimumab and Disalcid
This report displays the potential drug interactions for the following 2 drugs:
- adalimumab
- Disalcid (salsalate)
Interactions between your drugs
No interactions were found between adalimumab and Disalcid. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
adalimumab
A total of 553 drugs are known to interact with adalimumab.
- Adalimumab is in the following drug classes: antirheumatics, TNF alfa inhibitors.
-
Adalimumab is used to treat the following conditions:
- Ankylosing Spondylitis
- Behcet's Disease (off-label)
- Crohn's Disease
- Crohn's Disease, Active
- Crohn's Disease, Maintenance
- Hidradenitis Suppurativa
- Plaque Psoriasis
- Polyarticular Juvenile Idiopathic Arthritis
- Psoriasis
- Psoriatic Arthritis
- Reiter's Syndrome (off-label)
- Rheumatoid Arthritis
- Sarcoidosis (off-label)
- Spondyloarthritis (off-label)
- Ulcerative Colitis
- Uveitis
Disalcid
A total of 310 drugs are known to interact with Disalcid.
- Disalcid is in the drug class salicylates.
- Disalcid is used to treat the following conditions:
Drug and food interactions
salsalate food
Applies to: Disalcid (salsalate)
GENERALLY AVOID: The concurrent use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) and ethanol may lead to gastrointestinal (GI) blood loss. The mechanism may be due to a combined local effect as well as inhibition of prostaglandins leading to decreased integrity of the GI lining.
MANAGEMENT: Patients should be counseled on this potential interaction and advised to refrain from alcohol consumption while taking aspirin or NSAIDs.
References (1)
- (2002) "Product Information. Motrin (ibuprofen)." Pharmacia and Upjohn
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.